Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trials

International Journal of Cardiology

Volumn 202, Issue , 2016, Pages 228-237

  Bulluck, Heerajnarain ^a   Sirker, Alex ^a   Loke, Yoon K ^b   Garcia Dorado, David ^c   Hausenloy, Derek J ^a,d,e  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e DEPARTMENT OF CARDIOLOGY   (Singapore)

Author keywords

Adenosine; Adjunctive therapy; Primary percutaneous coronary intervention; Reperfusion injury; ST segment elevation myocardial infarction

Indexed keywords

ADENOSINE; VASODILATOR AGENT;

ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; HEART FAILURE; HEART MUSCLE REPERFUSION; HUMAN; INCIDENCE; META ANALYSIS; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW; ELECTROCARDIOGRAPHY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADENOSINE; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASODILATOR AGENTS;

EID: 84960154942     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.09.005     Document Type: Article

References (36)

1. D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury N. Engl. J. Med. 357 11 2007 1121 1135
2. G.M. Frohlich, P. Meier, S.K. White, D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury: looking beyond primary PCI Eur. Heart J. 34 23 2013 1714 1722
3. G.S. Liu, J. Thornton, D.M. Van Winkle, A.W. Stanley, R.A. Olsson, and J.M. Downey Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart Circulation 84 1 1991 350 356
4. J. Todd, Z.Q. Zhao, M.W. Williams, H. Sato, D.G. Van Wylen, and J. Vinten-Johansen Intravascular adenosine at reperfusion reduces infarct size and neutrophil adherence Ann. Thorac. Surg. 62 5 1996 1364 1372
5. M. Donato, and R.J. Gelpi Adenosine and cardioprotection during reperfusion - an overview Mol. Cell. Biochem. 251 1-2 2003 153 159
6. K.W. Mahaffey, J.A. Puma, N.A. Barbagelata, M.F. DiCarli, M.A. Leesar, K.F. Browne, and et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial J. Am. Coll. Cardiol. 34 6 1999 1711 1720
7. M. Marzilli, E. Orsini, P. Marraccini, and R. Testa Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction Circulation 101 18 2000 2154 2159
8. M. Quintana, P. Hjemdahl, A. Sollevi, T. Kahan, M. Edner, N. Rehnqvist, and et al. Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study Eur. J. Clin. Pharmacol. 59 1 2003 1 9
9. A. Micari, T.A. Belcik, E.A. Balcells, E. Powers, K. Wei, S. Kaul, and et al. Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting Am. J. Cardiol. 96 10 2005 1410 1415
10. A.S. Petronio, M. De Carlo, N. Ciabatti, G. Amoroso, U. Limbruno, C. Palagi, and et al. Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosine Am. Heart J. 150 5 2005 1015
11. A.M. Ross, R.J. Gibbons, G.W. Stone, R.A. Kloner, R.W. Alexander, and A.-I. Investigators A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II) J. Am. Coll. Cardiol. 45 11 2005 1775 1780
12. M.G. Stoel, K.M. Marques, C.C. de Cock, J.G. Bronzwaer, C. von Birgelen, and F. Zijlstra High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study Catheter. Cardiovasc. Interv. 71 3 2008 283 289
13. M.L. Fokkema, P.J. Vlaar, M. Vogelzang, Y.L. Gu, M.A. Kampinga, B.J. de Smet, and et al. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial Catheter. Cardiovasc. Interv. 2 4 2009 323 329
14. W. Desmet, J. Bogaert, C. Dubois, P. Sinnaeve, T. Adriaenssens, C. Pappas, and et al. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction Eur. Heart J. 32 7 2011 867 877
15. M. Grygier, A. Araszkiewicz, M. Lesiak, M. Janus, J. Kowal, W. Skorupski, and et al. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention Am. J. Cardiol. 107 8 2011 1131 1135
16. J. Wang, Y.D. Chen, G. Zhi, Y. Xu, L. Chen, H.B. Liu, and et al. Beneficial effect of adenosine on myocardial perfusion in patients treated with primary percutaneous coronary intervention for acute myocardial infarction Clin. Exp. Pharmacol. Physiol. 39 3 2012 247 252
17. H. Zhang, N.L. Tian, Z.Y. Hu, F. Wang, L. Chen, Y.J. Zhang, and S.L. Chen Three hours continuous injection of adenosine improved left ventricular function and infarct size in patients with ST-segment elevation myocardial infarction Chin. Med. J. 125 10 2012 1713 1719
18. G. Niccoli, S. Rigattieri, M.R. De Vita, M. Valgimigli, P. Corvo, F. Fabbiocchi, and et al. Open-Label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: The REOPEN-AMI Study (intracoronary nitroprusside versus adenosine in acute myocardial infarction) J. Am. Coll. Cardiol. Intv. 6 6 2013 580 589
19. M. Singh, T. Shah, K. Khosla, P. Singh, J. Molnar, S. Khosla, and et al. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials Ther. Adv. Cardiovasc. Dis. 6 3 2012 101 114
20. K. Aung Naing, L. Li, Q. Su, and T. Wu Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction Cochrane Database Syst. Rev. 6 2013 CD009503
21. E.P. Navarese, A. Buffon, F. Andreotti, P.A. Gurbel, M. Kozinski, A. Kubica, and et al. Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trials Atherosclerosis 222 1 2012 1 7
22. D. Garcia-Dorado, B. Garcia-Del-Blanco, I. Otaegui, J. Rodriguez-Palomares, V. Pineda, F. Gimeno, and et al. Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: a randomized controlled clinical trial Int. J. Cardiol. 177 3 2014 935 941
23. G. Niccoli, C. Spaziani, F. Crea, and R.-A. Investigators Left ventricular remodeling and 1-year clinical follow-up of the REOPEN-AMI trial J. Am. Coll. Cardiol. 63 14 2014 1454 1455
24. M. Grygier, A. Araszkiewicz, M. Lesiak, and S. Grajek Effect of new method of intracoronary adenosine injection during primary percutaneous coronary intervention on microvascular reperfusion injury - clinical outcome and 1-year follow-up Cardiology 124 3 2013 199 206
25. J.P. Higgins, D.G. Altman, P.C. Gotzsche, P. Juni, D. Moher, A.D. Oxman, and et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 2011 d5928
26. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, and P. Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 b2535
27. P. Juni, A. Witschi, R. Bloch, and M. Egger The hazards of scoring the quality of clinical trials for meta-analysis JAMA 282 11 1999 1054 1060
28. Z.G. Ji, J.M. Han, G. Liu, and K. Liu Effect of adenosine on ischemia-reperfusion injury during percutaneous coronary intervention J. Clin. Rehabil. Tissue Eng. Res. 11 51 2007 10,399 10,403
29. X. Wang, Z.J. Ding, and J.Z. Chen, J. Clin. Med. Pract. 12 5 2008
30. I.F. Akturk, A.A. Yalcin, I. Biyik, C. Sarikamis, N.T. Caglar, M. Erturk, and et al. Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction Minerva Cardioangiol. 62 5 2014 389 397
31. N. Ito, S. Nanto, Y. Doi, Y. Kurozumi, T. Natsukawa, H. Shibata, and et al. Beneficial effects of intracoronary nicorandil on microvascular dysfunction after primary percutaneous coronary intervention: demonstration of its superiority to nitroglycerin in a cross-over study Cardiovasc. Drugs Ther. 27 4 2013 279 287
32. D.J. Hausenloy, and D.M. Yellon Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection Heart Fail. Rev. 12 3-4 2007 217 234
33. R.M. Berne The role of adenosine in the regulation of coronary blood flow Circ. Res. 47 6 1980 807 813
34. P.B. Ernst, J.C. Garrison, and L.F. Thompson Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology J. Immunol. 185 4 2010 1993 1998
35. B. Olafsson, M.B. Forman, D.W. Puett, A. Pou, C.U. Cates, G.C. Friesinger, and et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon Circulation 76 5 1987 1135 1145
36. S.A. Nazir, J.N. Khan, I.Z. Mahmoud, J.P. Greenwood, D.J. Blackman, V. Kunadian, and et al. The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial Trials 15 2014 371